dipalmitoylphosphatidic acid has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
dipalmitoylphosphatidic acid: RN given refers to parent cpd without isomeric designation
dihexadecanoyl phosphatidic acid : A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dipalmitoylphosphatidic acid (DPPA) is a bioactive phospholipid." | 1.46 | Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer. ( Chen, J; Duan, YF; He, XD; Li, JC; Qi, CL; Wang, L; Yang, YX; Zhang, M; Zhang, QQ; Zhou, DL, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, QQ | 2 |
| Chen, J | 2 |
| Zhou, DL | 1 |
| Duan, YF | 1 |
| Qi, CL | 1 |
| Li, JC | 1 |
| He, XD | 1 |
| Zhang, M | 1 |
| Yang, YX | 1 |
| Wang, L | 2 |
| Zhou, Z | 1 |
| Yao, Y | 1 |
| Dai, J | 1 |
| Zhou, D | 1 |
2 other studies available for dipalmitoylphosphatidic acid and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferati | 2017 |
Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chick Embryo; C | 2018 |